Video

Sildenafil on Valvular Heart Disease & Residual Pulmonary Hypertension at ESC 2017

Published: 25 Sep 2017

  • Views:

    Views Icon 70

  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

This interview with Javier Bermejo from Hospital General Universitario Gregorio Marañon, Madrid, ES discusses the Effect of Sildenafil on Clinical Outcomes in Patients with Corrected Valvular Heart Disease and Residual Pulmonary Hypertension (SIOVAC) at ESC 2017.

Filmed by Radcliffe Cardiology on-site at EASD 2017.